ATXN2L

Ataxin-2-like protein · Q8WWM7 · ATXN2L on Sugi Atlas →

0 patent compounds predicted against ATXN2L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ATXN2L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL) PHASE3COMPLETED
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD PHASE1/PHASE2RECRUITING
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 PHASE1RECRUITING
Clinical Trial Readiness for SCA1 and SCA3 nanUNKNOWN
Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes nanUNKNOWN
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias nanUNKNOWN
Natural History of Spinocerebellar Ataxia Type 7 (SCA7) nanRECRUITING
Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD nanUNKNOWN
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) nanCOMPLETED
Biomarkers in Autosomal Dominant Cerebellar Ataxia nanCOMPLETED
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases nanACTIVE_NOT_RECRUITING
Integrated Functional Evaluation of the Cerebellum nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Core Stability Exercises and Hereditary Ataxia nanCOMPLETED
Sporadic Degenerative Ataxia With Adult Onset: Natural History Study nanRECRUITING
Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial nanUNKNOWN
Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia nanRECRUITING
Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T nanCOMPLETED
FA Clinical Outcome Measures nanACTIVE_NOT_RECRUITING
Genetic Mechanism of Conserved Ancestral Haplotype in SCA10 nanUNKNOWN
Hong Kong Spinocerebellar Ataxias Registry nanRECRUITING
Characteristics of Episodic Ataxia Syndrome nanCOMPLETED
Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38 nanCOMPLETED
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias nanCOMPLETED
Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation on Cognitive Impairment Associated to Movement Disorders nanCOMPLETED
The EUROSCA Natural History Study nanRECRUITING
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias nanCOMPLETED
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS) nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ATXN2L binder may also engage these)

ProteinNameSimilarity
Q7TQH0 1.000 Q7TQH0 →
Q80TZ9 0.988 Q80TZ9 →
Q8SWR8 0.988 Q8SWR8 →
Q62901 0.987 Q62901 →
Q9BTA9 0.987 Q9BTA9 →
Q96L91 0.986 Q96L91 →
Q6NZJ6 0.986 Q6NZJ6 →
Q29A33 0.986 Q29A33 →
Q9VIV2 0.986 Q9VIV2 →
Q58NQ4 0.985 Q58NQ4 →
Q7ZUK7 0.985 Q7ZUK7 →
Q9H334 0.985 Q9H334 →
P23899 0.985 P23899 →
Q9R0I7 0.984 Q9R0I7 →
P0CB49 0.984 P0CB49 →
Q62431 0.984 Q62431 →
Q8CHI8 0.984 Q8CHI8 →
P24610 0.984 P24610 →
PRRC2A Protein PRRC2A 0.984 landscape →
Q80XI3 0.984 Q80XI3 →
POU2F2 POU domain, class 2, transcription factor 2 0.984 landscape →
NFRKB Nuclear factor related to kappa-B-binding protein 0.984 landscape →
Q63627 0.984 Q63627 →
Q06453 0.984 Q06453 →
Q5CZI8 0.984 Q5CZI8 →
Q8K0V4 0.984 Q8K0V4 →
Q9Y2H5 0.984 Q9Y2H5 →
A0JMU8 0.984 A0JMU8 →
Q6DDH6 0.984 Q6DDH6 →
A0A8C0NGY6 0.983 A0A8C0NGY6 →